Jubilant Ingrevia Ltd is Rated Sell by MarketsMOJO

2 hours ago
share
Share Via
Jubilant Ingrevia Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Jubilant Ingrevia Ltd is Rated Sell by MarketsMOJO

Current Rating and Its Significance

MarketsMOJO currently assigns Jubilant Ingrevia Ltd a 'Sell' rating, reflecting a cautious stance on the stock. This rating indicates that, based on a comprehensive evaluation of the company’s quality, valuation, financial trends, and technical indicators, investors should consider reducing exposure or avoiding new purchases at this time. The 'Sell' grade suggests that the stock may underperform relative to the broader market or its sector peers in the near to medium term.

Quality Assessment

As of 11 May 2026, Jubilant Ingrevia’s quality grade is assessed as average. This reflects a mixed operational performance over recent years. The company has struggled with long-term growth, as net sales have declined at an annualised rate of -0.45% over the past five years. Operating profit has seen a sharper contraction, falling at an annual rate of -13.67% during the same period. Such trends indicate challenges in sustaining profitability and operational efficiency, which weigh on the overall quality score.

Valuation Perspective

The valuation grade for Jubilant Ingrevia is currently fair. While the stock trades at levels that do not appear excessively stretched, the valuation does not offer a compelling margin of safety given the company’s subdued growth prospects and profitability pressures. Investors should note that fair valuation implies the stock is priced roughly in line with its intrinsic worth, but without significant upside potential based on current fundamentals.

Financial Trend Analysis

The financial trend for Jubilant Ingrevia is negative as of today. Key indicators highlight deteriorating profitability and operational challenges. The latest quarterly profit after tax (PAT) stands at ₹56.25 crores, representing a decline of 21.9% compared to the average of the previous four quarters. Additionally, the company’s debtors turnover ratio is at a low 5.56 times, signalling slower collections and potential working capital inefficiencies. The operating profit to interest coverage ratio is also at a low 10.16 times, indicating tighter margins to service debt obligations. These factors collectively contribute to a cautious outlook on the company’s financial health.

Technical Indicators

From a technical standpoint, Jubilant Ingrevia exhibits a mildly bullish trend. The stock has delivered positive returns over recent periods, with gains of 11.76% over the past month and 8.89% over six months. Year-to-date returns stand at 2.96%, and the one-year return is 4.15%. Despite these gains, the stock experienced a 2.55% decline on the most recent trading day, reflecting some volatility. The mildly bullish technical grade suggests that while short-term momentum exists, it is not strong enough to offset the fundamental concerns fully.

Stock Performance Overview

As of 11 May 2026, Jubilant Ingrevia’s stock performance presents a mixed picture. The stock has shown resilience with modest gains over the medium term, but the underlying fundamentals remain under pressure. Investors should weigh the recent positive price momentum against the company’s operational and financial challenges before making investment decisions.

Implications for Investors

The 'Sell' rating serves as a cautionary signal for investors. It suggests that Jubilant Ingrevia may face headwinds that could limit capital appreciation or increase downside risk. Investors with existing positions might consider reviewing their exposure, while prospective buyers should carefully analyse the company’s financial trajectory and sector dynamics before committing capital. The rating underscores the importance of balancing technical momentum with fundamental realities in portfolio decisions.

Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.

  • - Consistent quarterly delivery
  • - Proven staying power
  • - Stability with growth

See the Consistent Performer →

Company Profile and Market Context

Jubilant Ingrevia Ltd operates within the specialty chemicals sector and is classified as a small-cap company. The sector is known for its cyclical nature and sensitivity to raw material costs and global demand fluctuations. Jubilant Ingrevia’s current market capitalisation reflects its niche positioning but also highlights the challenges faced in scaling operations and maintaining consistent profitability.

Mojo Score and Rating Evolution

The company’s Mojo Score currently stands at 47.0, which corresponds to the 'Sell' grade. This score improved from a previous 28, which was classified as 'Strong Sell' before 07 Apr 2026. The increase of 19 points in the Mojo Score indicates some improvement in certain parameters, but not sufficient to warrant a more positive rating. The score integrates multiple factors including quality, valuation, financial trends, and technicals to provide a holistic view of the stock’s investment merit.

Conclusion: A Balanced View on Jubilant Ingrevia

In summary, Jubilant Ingrevia Ltd’s current 'Sell' rating reflects a nuanced assessment of its operational challenges, valuation fairness, negative financial trends, and modest technical momentum. Investors should approach the stock with caution, recognising that while there are some positive price movements, the underlying fundamentals suggest limited upside potential and ongoing risks. Continuous monitoring of quarterly results and sector developments will be essential for those holding or considering this stock.

Key Takeaways for Investors

Investors should consider the following points when evaluating Jubilant Ingrevia:

  • Long-term sales and operating profit have declined, signalling growth challenges.
  • Current valuation is fair but does not offer significant upside given fundamentals.
  • Financial metrics indicate pressure on profitability and working capital efficiency.
  • Technical indicators show mild bullishness but with recent volatility.
  • The 'Sell' rating advises prudence and careful portfolio management.

By understanding these factors, investors can make more informed decisions aligned with their risk tolerance and investment objectives.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News